Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lingor

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Microbiology Spectrum|January 9, 2023
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care WorkersRuth Aguilar, Xue Li, Claudia S Crowell, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.
Neurology|November 1, 2023
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson DiseaseDominik Pürner, Mohammad Hormozi, Daniel Weiß, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|May 21, 2020
Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilitiesAndreas H Jacobs, Kirsten Emmert, Ralf Baron, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Annals of Neurology|August 9, 2025
Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1-Linked Amyotrophic Lateral SclerosisChristina Steffke, Karthik Baskar, Franziska Bachhuber, et al.
Microbiology Spectrum|January 9, 2023
RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care WorkersRuth Aguilar, Xue Li, Claudia S Crowell, et al.
Brain Communications|May 24, 2023
Spectrum and frequency of genetic variants in sporadic amyotrophic lateral sclerosisWolfgang P Ruf, Matej Boros, Axel Freischmidt, et al.
Neurological Research and Practice|August 20, 2025
Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Neurological Research and Practice|July 3, 2024
Patients' and caregivers' perception of multidimensional and palliative care in amyotrophic lateral sclerosis - protocol of a German multicentre studyKatharina Linse, Constanze Weber, Peter Reilich, et al.
Neurology|November 1, 2023
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson DiseaseDominik Pürner, Mohammad Hormozi, Daniel Weiß, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|May 21, 2020
Neurogeriatrics-a vision for improved care and research for geriatric patients with predominating neurological disabilitiesAndreas H Jacobs, Kirsten Emmert, Ralf Baron, et al.
The Lancet Regional Health. Europe|February 16, 2024
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational studyRené Günther, Claudia Diana Wurster, Svenja Brakemeier, et al.
Pageof 18